Sun Pharmaceutical Industries Inc recalls Carbamazepine Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
- Products
-
- Carbamazepine Tablets
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 1968 Bottles (1000Tablets/Bottle)
- About this recall
- Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.